Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
42
NDEV Quote, Financials, Valuation and Earnings
Last price:
$0.0200
Seasonality move
:
53.28%
Day range:
$0.0150 - $0.0150
52-week range:
$0.0054 - $0.0850
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.92x
P/B ratio:
0.87x
Volume:
1.4K
Avg. volume:
40.7K
1-year change:
-76.38%
Market cap:
$1.6M
Revenue:
$368.7K
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Novus Acquisition & Development Corp. has -- downside to fair value with a price target of -- per share.
NDEV vs. S&P 500
-
Over the past 5 trading days, Novus Acquisition & Development Corp. has underperformed the S&P 500 by -7.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Novus Acquisition & Development Corp. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Novus Acquisition & Development Corp. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Novus Acquisition & Development Corp. reported revenues of --.
Earnings Growth
-
Novus Acquisition & Development Corp. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Novus Acquisition & Development Corp. reported earnings per share of --.
Enterprise value:
1.6M
EV / Invested capital:
--
Price / LTM sales:
3.92x
EV / EBIT:
7.18x
EV / Revenue:
3.34x
PEG ratio (5yr expected):
0.42x
EV / Free cash flow:
30.09x
Price / Operating cash flow:
35.27x
Enterprise value / EBITDA:
7.18x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $316.5K | $347.6K | $466.4K | $89.2K | $97.7K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $75.7K | $154.1K | $217.1K | $40.4K | $46.8K | |
| EBITDA | $75.7K | $154.1K | $217.1K | $40.4K | $46.8K | |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $169.3K | $191.9K | $205K | $224.3K | |
| Total Assets | -- | $1.7M | $1.7M | $1.8M | $1.9M | |
| Current Liabilities | -- | $143.8K | $150.9K | $158.1K | $165.2K | |
| Total Liabilities | -- | $143.8K | $150.9K | $158.1K | $165.2K | |
| Total Equity | -- | $1.6M | $1.7M | $1.7M | $1.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $124.3K | $151.3K | $51.8K | $40.4K | $46.8K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | $124.3K | $151.3K | $51.8K | $40.4K | $46.8K | |
NDEV
Sector
Market Cap
$1.6M
$573.1M
Price % of 52-Week High
17.65%
91.76%
Dividend Yield
0%
1.6%
Shareholder Yield
--
3.13%
1-Year Price Total Return
-76.38%
4.4%
Beta (5-Year)
-0.509
0.481
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0157
200-day SMA
Sell
Level
$0.0338
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.0157
Relative Strength Index (RSI14)
Sell
Level
45.4824
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-37.1795
50-day SMA
Sell
Level
$0.0180
MACD (12, 26)
Sell
Level
-0.0011
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (19.666)
Buy
CA Score
(Annual)
Level (2.2236)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Buy
Ohlson Score
Level (-1.456)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Novus Acquisition & Development Corp. engages as a private equity firm for self-funding in the acquisition of one or more operating businesses. The company provides discounted medical plans and supplemental insurance programs that assist patients with discounts within alternative medicine. The company was founded on November 11, 1996 and is headquartered in Miami, FL.
Stock Forecast FAQ
In the current month, NDEV has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NDEV average analyst price target in the past 3 months is --.
-
Where Will Novus Acquisition & Development Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Novus Acquisition & Development Corp. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Novus Acquisition & Development Corp.?
Analysts are divided on their view about Novus Acquisition & Development Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Novus Acquisition & Development Corp. is a Sell and believe this share price will rise from its current level to --.
-
What Is Novus Acquisition & Development Corp.'s Price Target?
The price target for Novus Acquisition & Development Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NDEV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Novus Acquisition & Development Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NDEV?
You can purchase shares of Novus Acquisition & Development Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Novus Acquisition & Development Corp. shares.
-
What Is The Novus Acquisition & Development Corp. Share Price Today?
Novus Acquisition & Development Corp. was last trading at $0.0200 per share. This represents the most recent stock quote for Novus Acquisition & Development Corp.. Yesterday, Novus Acquisition & Development Corp. closed at $0.0150 per share.
-
How To Buy Novus Acquisition & Development Corp. Stock Online?
In order to purchase Novus Acquisition & Development Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NDEV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NDEV
Sector
P/E ratio
--
12.21x
PEG ratio
0.42x
0.32x
P/B ratio
0.87x
1.12x
Price / LTM sales
3.92x
1.84x
Growth Metrics
NDEV
Sector
Revenue growth
--
5.62%
Earnings growth
--
15.03%
Revenue (5-year growth)
10.96%
8.86%
Earnings forecast
--
$0.62
Profitability
NDEV
Sector
Profitability FY 2024
--
--
Return on invested capital
--
5.03%
Return on assets
--
1.02%
Return on equity
--
9.68%
Earnings Date
Last Earnings Date
Aug
9
Next Earnings Date
Dec
17
Estimated Next Earnings Date
Mar
18
Balance Sheet
NDEV
Sector
Total cash
--
$436.6M
Short term investments
--
$211.5M
Total assets
$1.9M
$3.1B
Long term debt
--
$82.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
39
SMX alert for Dec 17
SMX (Security Matters) Plc [SMX] is up 12.21% over the past day.
Sell
45
ZBIO alert for Dec 17
Zenas BioPharma, Inc. [ZBIO] is down 1.38% over the past day.
Buy
75
AFRM alert for Dec 17
Affirm Holdings, Inc. [AFRM] is up 0.44% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
